PRESS RELEASE published on 04/30/2024 at 20:30, 1 year 9 months ago Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. Spexis AG receives approval to extend deadline for publishing 2023 annual report and audited financials until May 31, 2024, due to ongoing legal discussions and negotiations with creditors Extension 2023 Annual Report Spexis AG Deadline Audited Financials
BRIEF published on 04/17/2024 at 07:20, 1 year 9 months ago Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRIEF published on 04/17/2024 at 07:20, 1 year 9 months ago Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
PRESS RELEASE published on 04/17/2024 at 07:15, 1 year 9 months ago Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
PRESS RELEASE published on 02/08/2024 at 07:15, 2 years ago Spexis announces closing of sale of preclinical antibiotics program to Basilea Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
PRESS RELEASE published on 11/08/2023 at 07:15, 2 years 3 months ago Spexis to file an application for a debt-restructuring moratorium
PRESS RELEASE published on 11/01/2023 at 07:20, 2 years 3 months ago Spexis Announces Changes to the Executive Committee
PRESS RELEASE published on 10/06/2023 at 07:30, 2 years 4 months ago Spexis to host business update conference call on October 9, 2023
PRESS RELEASE published on 09/29/2023 at 07:25, 2 years 4 months ago Spexis provides business update and announces financial results for the first half of 2023
PRESS RELEASE published on 09/28/2023 at 07:30, 2 years 4 months ago Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
Published on 02/13/2026 at 08:00, 3 hours 57 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 02/13/2026 at 00:20, 11 hours 37 minutes ago Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale
Published on 02/13/2026 at 00:10, 11 hours 47 minutes ago Irving Resources Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 02/12/2026 at 23:25, 12 hours 32 minutes ago The Caldwell Partners International Announces Results of Vote for Election of Directors
Published on 02/12/2026 at 22:00, 13 hours 57 minutes ago Electrovaya Reports Fiscal Year Q1 2026 Results
Published on 02/13/2026 at 11:29, 27 minutes ago EQS-Adhoc: IVU Traffic Technologies AG: IVU Traffic Technologies AG decides to buy back shares
Published on 02/13/2026 at 10:45, 1 hour 12 minutes ago Partnership with Finland’s GTK and Betolar on Epanko Mine Tailings
Published on 02/13/2026 at 09:30, 2 hours 27 minutes ago Banyan Group Residences Introduces Angsana Golf Residences Topaz at Laguna Phuket
Published on 02/13/2026 at 09:00, 2 hours 56 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 02/13/2026 at 07:00, 4 hours 57 minutes ago Safran reports excellent financial performance in 2025 and raises its 2028 ambitions
Published on 02/13/2026 at 07:00, 4 hours 57 minutes ago Safran annonce une excellente performance financière en 2025 et relève ses ambitions pour 2028
Published on 02/12/2026 at 21:30, 14 hours 26 minutes ago Aéroports de Paris SA - 2026 Airport charges in Paris
Published on 02/12/2026 at 21:30, 14 hours 26 minutes ago Aéroports de Paris SA - Processus d'homologation tarifaire 2026